Athersys is a Cleveland, Ohio based company developing a growing pipeline of therapeutics designed to treat cardiovascular disease and other conditions. Athersys is currently developing pharmaceutical-like cell therapies, based upon its proprietary multipotent adult progenitor cell technology, for the treatment of congestive heart failure, acute myocardial infarction and other cardiovascular conditions.


Get In Touch With Us